Cargando…

Screening and Identifying Cisplatin-Related Gene Mutations in Lung Squamous Cell Carcinoma

INTRODUCTION: Platinum-based chemotherapy is the cornerstone of treatment for patients with LUSC, but cisplatin resistance greatly restricts its clinical application. Therefore, it is particularly important to screen the predominant LUSC population using biomarkers. METHODS: Data for 15 LUSC cell li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaohua, Wang, Yuntao, Hu, Sheng, Bai, Yifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755377/ https://www.ncbi.nlm.nih.gov/pubmed/33376383 http://dx.doi.org/10.2147/PGPM.S264545

Ejemplares similares

Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2022)

Mutations in the TTN Gene are a Prognostic Factor for Patients with Lung Squamous Cell Carcinomas
por: Zou, Sheng, et al.
Publicado: (2022)

Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Li, Long, et al.
Publicado: (2016)

Leveraging methylation to identify the potential causal genes associated with survival in lung adenocarcinoma and lung squamous cell carcinoma
por: Liu, Lu, et al.
Publicado: (2020)

Assessing Gene Expression Related to Cisplatin Resistance in Human Oral Squamous Cell Carcinoma Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2022)

The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC
por: Li, Xiaohua, et al.
Publicado: (2021)

Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma
por: Wang, Youyu, et al.
Publicado: (2021)

Mutational signatures in squamous cell carcinoma of the lung
por: Osoegawa, Atsushi, et al.
Publicado: (2021)

KRAS Mutations in Squamous Cell Carcinomas of the Lung
por: Acker, Fabian, et al.
Publicado: (2021)

Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma
por: Li, Chenguang, et al.
Publicado: (2015)

Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma
por: Sheng, Shuyan, et al.
Publicado: (2022)

Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
por: Yu, Xinfang, et al.
Publicado: (2017)

Multiple mutations of lung squamous cell carcinoma shared common mechanisms
por: Li, Qianping, et al.
Publicado: (2016)

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma
por: Hu, Xiaoshan, et al.
Publicado: (2022)

Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
por: Haakensen, Vilde D., et al.
Publicado: (2020)

Clinical significance of miRNA-1 and its potential target gene network in lung squamous cell carcinoma
por: Li, Xiaojiao, et al.
Publicado: (2019)

Whole transcriptome sequencing identifies tumor-specific mutations in human oral squamous cell carcinoma
por: Zhang, Qu, et al.
Publicado: (2013)

Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Luo, Sheng-Dean, et al.
Publicado: (2015)

Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma
por: Gu, Chang, et al.
Publicado: (2021)

Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line
por: Zhang, Ping, et al.
Publicado: (2006)

Weighted gene expression profiles identify diagnostic and prognostic genes for lung adenocarcinoma and squamous cell carcinoma
por: Wu, Xing, et al.
Publicado: (2019)

Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations
por: Chang, Jiang, et al.
Publicado: (2017)

Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma
por: Xie, Xiaona, et al.
Publicado: (2021)

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2020)

Cross-disease analysis identified novel common genes for both lung adenocarcinoma and lung squamous cell carcinoma
por: Zhang, Guanghui, et al.
Publicado: (2019)

Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction
por: Wu, Hua-Tao, et al.
Publicado: (2020)

A network-based method for identifying prognostic gene modules in lung squamous carcinoma
por: Feng, Lin, et al.
Publicado: (2016)

An investigation to identify tumor microenvironment-related genes of prognostic value in lung squamous cell carcinoma based on The Cancer Genome Atlas
por: Liu, Huan, et al.
Publicado: (2021)

The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines
por: Jo, Deuk-Won, et al.
Publicado: (2016)

Analysis of radon-associated squamous cell carcinomas of the lung for ap53 gene hotspot mutation
por: Yang, Q, et al.
Publicado: (2000)

Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma
por: Li, Tingting, et al.
Publicado: (2022)

Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
por: Viet, Chi T., et al.
Publicado: (2014)

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck
por: Huang, Kie Kyon, et al.
Publicado: (2016)

Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
por: Ji, Yanzhen, et al.
Publicado: (2023)

Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2020)

Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy
por: Wang, Yan-Yang, et al.
Publicado: (2016)

Novel mutational landscapes and expression signatures of lung squamous cell carcinoma
por: Xiong, Donghai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2t0vqgeujja8r9172cg7g9182r